Block; Dirk
Patent Applications and Registrations
Patent applications and USPTO patent grants for Block; Dirk.The latest application filed is for "marker for statin treatment stratification in heart failure".
Company Profile
14.24.41
- Block; Dirk - Bichl DE
Patent Activity
| Patent | Date |
|---|---|
| Assessing whether a subject shall be subjected to imaging based diagnostic Grant 11,454,634 - Block , et al. September 27, 2 | 2022-09-27 |
| IGFBP7 for prediction of risk of AKI when measured prior to surgery Grant 11,397,187 - Horsch , et al. July 26, 2 | 2022-07-26 |
| Marker For Statin Treatment Stratification In Heart Failure App 20220206015 - BLOCK; Dirk ; et al. | 2022-06-30 |
| Biomarkers In The Selection Of Therapy Of Heart Failure App 20220034910 - ZAUGG; Christian ; et al. | 2022-02-03 |
| IGFBP7 for diagnosing diastolic dysfunction Grant 11,047,866 - Karl , et al. June 29, 2 | 2021-06-29 |
| Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure App 20210164969 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2021-06-03 |
| Use of IGFBP-7 in the assessment of heart failure Grant 10,996,229 - Wienhues-Thelen , et al. May 4, 2 | 2021-05-04 |
| Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure Grant 10,942,175 - Wienhues-Thelen , et al. March 9, 2 | 2021-03-09 |
| Biomarkers For Risk Prediction Of Mortality App 20200371114 - Latini; Roberto ; et al. | 2020-11-26 |
| Biomarkers For Risk Assessment And Treatment Monitoring In Heart Failure Patients Guided By Natriuretic Peptides App 20200271670 - Block; Dirk ; et al. | 2020-08-27 |
| Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides Grant 10,684,291 - Block , et al. | 2020-06-16 |
| Use Of Igfbp-7 In The Assessment Of Heart Failure App 20200064359 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2020-02-27 |
| Biomarkers for risk prediction of mortality Grant 10,557,858 - Latini , et al. Feb | 2020-02-11 |
| Use of IGFBP-7 in the assessment of heart failure Grant 10,488,422 - Wienhues-Thelen , et al. Nov | 2019-11-26 |
| Circulating Angiopoietin-2 (ang-2) For The Prediction Of Recurrence Of Atrial Fibrillation App 20190353666 - Andres; Herbert ; et al. | 2019-11-21 |
| Igfbp7 For Diagnosing Diastolic Dysfunction App 20190277861 - Karl; Johann ; et al. | 2019-09-12 |
| Soluble St2 For The Identification Of Progressors To Lvh In The General Population App 20190279770 - Block; Dirk ; et al. | 2019-09-12 |
| IGFBP7 for diagnosing diastolic dysfunction Grant 10,345,315 - Karl , et al. July 9, 2 | 2019-07-09 |
| Marker For Statin Treatment Stratification In Heart Failure App 20190154706 - Block; Dirk ; et al. | 2019-05-23 |
| Marker for statin treatment stratification in heart failure Grant 10,234,464 - Block , et al. | 2019-03-19 |
| Use of mimecan in the assessment of heart failure Grant 10,234,462 - Block , et al. | 2019-03-19 |
| Igfbp-7 As A Marker Of Preeclampsia App 20180364248 - Hund; Martin ; et al. | 2018-12-20 |
| NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILURE App 20180313850 - Block; Dirk ; et al. | 2018-11-01 |
| Igfbp7 For Prediction Of Risk Of Aki When Measured Prior To Surgery App 20180231570 - Horsch; Andrea ; et al. | 2018-08-16 |
| Identification Of Patients With Abnormal Fractional Shortening App 20180196067 - Block; Dirk ; et al. | 2018-07-12 |
| Method for bisulfite treatment Grant 9,868,756 - Markert-Hahn , et al. January 16, 2 | 2018-01-16 |
| Biomarkers For Risk Prediction Of Mortality App 20170227552 - Latini; Roberto ; et al. | 2017-08-10 |
| TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION App 20170074892 - Block; Dirk ; et al. | 2017-03-16 |
| Use Of Igfbp-7 In The Assessment Of Heart Failure App 20170016918 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2017-01-19 |
| Igfbp7 For Diagnosing Diastolic Dysfunction App 20170010283 - Karl; Johann ; et al. | 2017-01-12 |
| Biomarkers For Risk Assessment And Treatment Monitoring In Heart Failure Patients Guided By Natriuretic Peptides App 20160334419 - Block; Dirk ; et al. | 2016-11-17 |
| Method for bisulfite treatment Grant 9,394,332 - Markert-Hahn , et al. July 19, 2 | 2016-07-19 |
| Marker For Statin Treatment Stratification In Heart Failure App 20160169911 - Block; Dirk ; et al. | 2016-06-16 |
| Use Of Alpha-crystallin B (cryab) In The Assessment Of Heart Failure App 20160146836 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2016-05-26 |
| Method for bisulfite treatment App 20160068888 - Markert-Hahn; Christine ; et al. | 2016-03-10 |
| Use of SLIM-1 in the assessment of heart failure Grant 9,267,954 - Wienhues-Thelen , et al. February 23, 2 | 2016-02-23 |
| Use Of Igfbp-7 In The Assessment Of Heart Failure App 20150293122 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2015-10-15 |
| Biomarkers In The Selection Of Therapy Of Heart Failure App 20150268251 - Zaugg; Christian ; et al. | 2015-09-24 |
| TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION App 20150233946 - Block; Dirk ; et al. | 2015-08-20 |
| NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILURE App 20150233945 - Block; Dirk ; et al. | 2015-08-20 |
| Identification Of Patients With Abnormal Fractional Shortening App 20150185230 - Block; Dirk ; et al. | 2015-07-02 |
| Use Of Biomarkers In The Assessment Of The Early Transition From Arterial Hypertension To Heart Failure App 20150079615 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2015-03-19 |
| Method and device for purifying nucleic acids Grant 8,927,261 - Block , et al. January 6, 2 | 2015-01-06 |
| Use Of Sfrp-3 In The Assessment Of Heart Failure App 20140193845 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2014-07-10 |
| Use of SFRP-3 in the assessment of heart failure Grant 8,691,587 - Wienhues-Thelen , et al. April 8, 2 | 2014-04-08 |
| Use Of Biomarkers In The Assessment Of The Early Transition From Arterial Hypertension To Heart Failure App 20140065648 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2014-03-06 |
| Method and Device for Purifying Nucleic Acids App 20120152818 - Block; Dirk ; et al. | 2012-06-21 |
| Use Of Mimecan In The Assessment Of Heart Failure App 20120156703 - Block; Dirk ; et al. | 2012-06-21 |
| Method and device for purifying nucleic acids Grant 8,158,349 - Block , et al. April 17, 2 | 2012-04-17 |
| Endostatin As A Marker Of Heart Failure App 20120009610 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2012-01-12 |
| Use Of Biglycan In The Assessment Of Heart Failure App 20110165591 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2011-07-07 |
| Method and Device for Purifying Nucleic Acids App 20110137020 - Block; Dirk ; et al. | 2011-06-09 |
| Method and device for purifying nucleic acids Grant 7,897,378 - Block , et al. March 1, 2 | 2011-03-01 |
| Use Of Sfrp-3 In The Assessment Of Heart Failure App 20110027819 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2011-02-03 |
| Use Of Slim-1 In The Assessment Of Heart Failure App 20100285492 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2010-11-11 |
| Use Of Igfbp-7 In The Assessment Of Heart Failure App 20100285491 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2010-11-11 |
| Method for bisulfite treatment Grant 7,413,855 - Bergmann , et al. August 19, 2 | 2008-08-19 |
| Method for bisulfite treatment App 20060058518 - Bergmann; Frank ; et al. | 2006-03-16 |
| Method and device for purifying nucleic acids App 20050208548 - Block, Dirk ; et al. | 2005-09-22 |
| Method for bisulfite treatment App 20040241704 - Markert-Hahn, Christine ; et al. | 2004-12-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 